Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3600223 A
Publication typeGrant
Publication dateAug 17, 1971
Filing dateDec 15, 1969
Priority dateDec 15, 1969
Publication numberUS 3600223 A, US 3600223A, US-A-3600223, US3600223 A, US3600223A
InventorsGlick Arthur, Mccusker Edward Joseph
Original AssigneeAmerican Cyanamid Co
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Process for cleaning polyglycolic acid fliaments useful as absorbable surgical sutures
US 3600223 A
Images(1)
Previous page
Next page
Description  (OCR text may contain errors)

Aug. 17, 1971 A. GLICK ETAL 3,600,223

v PROCESS FOR CLEANING POLYGLYCOLIC ACID FILAMENTS USEFUL AS ABSORBABLE SURGICAL SUTURES Filed Dec. 15, 1969 GENE/PA 70/2 [3a /2 TRANSDUCE R/ZE D 74 NK W4 TE/P OUT WA TER IN SURFA C WIN 7' 29 INVENTORS A THUR GL C K EDWARD J M CUSKEI'? B AGE/VT United States Patent 3,600,223 PROCESS FOR CLEANING POLYGLYCOLIC ACID FILAMENTS USEFUL AS ABSORBABLE SURGI- CAL SUTURES Arthur Glick and Edward Joseph McCusker, Danbury, Conn., assignors to American Cyanamid (lompany, Stamford, Conn.

Filed Dec. 15, 1969, Ser. No. 884,867 Int. Cl. B081!) 7/00 US. Cl. 134-1 10 Claims ABSTRACT OF THE DISCLOSURE Polyglycolic acid filaments containing surface soil are effectively cleaned by contacting them with ultrasonically agitated solutions, said solutions comprising a solvent and from 1% to 10% by weight of a biologically innocuous surfactant.

BACKGROUND OF THE INVENTION US. Patent 3,297,033 (incoroprated herein by reference) discloses that polyglycolic acid can be used to prepare acceptable absorbable sutures for use in humans and animals thereby affording a long sought after substitute for the catgut sutures heretofore used for this purpose. Polyglycolic acid is typically spun into a multifilament which is separated into bundles of appropriate dimensions for use as sleeves and cores in standardized braiding procedures. The strands and cores are then braided to form a suture braid of the desired diameter. Both prior to the braiding step and, in particular, during the braiding step, the filaments are subjected to processing conditions which may, on occasion, cause surface soiling of the filaments. This surface soiling is reflected by the change in color of the filaments from an unblemished pearl color (the natural color of polyglycolic acid) to a substantially uniform grayish color. Such coloration indicates that the filaments are contaminated with oily or greasy substances to which the filaments can be exposed during their processing. This discoloration and contamination of the suture is intolerable in a product which must not only meet the stringent aesthetic standards of the medical profession but which is also destined for implantation in the living tissue of the body. Obviously to meet such requirements clean filaments are essential. The term clean when used with respect to the polyglycolic acid braids means braids which have a uniform pearl color, and which are substantially free from oily, greasy substances, and other similar foreign matter.

The cleaning of a medical product such as a suture raises many problems not found in the more typical industrial cleaning applications. For example, the cleaning procedure must produce no adverse effect on either the package or in-vivo tensile strength of the suture. Such effects might be expected if excessive temperatures or residence times in cleaning baths are used or if the cleaning agent in some Way interacts with the suture. Moreover, there is the possibility of cleaning agent remaining on the suture from the cleaning operation which may be toxic or irritating to living tissue when the suture is implanted herein. Furthermore, since the product is absorbable, it must be thoroughly cleaned. Therefore, when the suture ice is a braid with numerous interstitial voids, penetration of the cleaning agent into these voids must be assured to guarantee removal of soil from all of the filament surfaces. The above problems can be conveniently overcome by employing the cleaning process of this invention.

SUMMARY OF THE INVENTION This invention relates to a process for cleaning filaments of polyglycolic acid which are useful as absorbable surgical sutures. In accordance with said process, polyglycolic acid filaments of acceptable cleanliness are prepared by contacting polyglycolic acid filaments having surface soiling with an ultrasonically agitated solution comprising:

(a) a liquid selected from the group consisting of water and organic solvents having an affinity to dissolve, emulsify, or entrain the oily, greasy contaminant on the surfaces of the polyglycolic acid filament; and

(b) a surfactant which is biologically innocuous towards living tissue, the amount of said surfactant in the solution ranging from about 1% to about 10% by weight;

at temperatures ranging from 20 C. to C. for at least about 10 seconds whereby said surface soiling is dissolved, emulsified, or entrained in said solution and thereby removed from contact with the filament when the solution is removed from contact with the filament.

A surfactant is biologically innocuous towards living tissue when it is substantially non-toxic and non-inflammatory towards the tissue so as to safely permit its usage within the body.

The surface soiled filaments may be contacted with the solution one or more times although ordinarily a single contact is sufficient to adequately clean the filament.

It has been found that ultrasonic agitation of the above described solution is essential for achieving adequate cleaning of the braid. Mechanical agitation and other conventional methods of agitation have proved unsuccessful. Whereas filaments can be adequately cleaned in a few seconds using ultrasonic agitation of the bath, the same filaments can sit for hours in the same bath without ultrasonic agitation with little, if any, detectable cleaning of the filament taking place.

It has been further found that if feasible residence times in the cleaning bath are to be obtained, it is essential that the bath contain a surfactant. Whereas filaments can be adequately cleaned in an ultrasonically agitated solution containing a surfactant in a very short time, the same filament when placed in :an ultrasonically agitated bath not containing surfactant can remain dirty even after several hours in the bath.

It thus becomes apparent that ultrasonic agitation without addition of a surfactant to the bath is unsatisfactory. Similarly, addition of a surfactant to the bath without ultrasonic agitation is also unsatisfactory. It is only when ultrasonic agitation is applied to a bath which contains a surfactant that adequate cleaning is achieved. In such cases cleaning is achieved with bath residence times as short as 10 seconds. When filament is being processed on a continuous basis, it is, of course, desirable that residence times in a cleaning bath be as short as possible in order that the filament cleaning step not become a bottleneck in the overall process.

3 BRIEF DESCRIPTION OF THE DRAWING The figure is a schematic flowsheet depicting an embodiment of the process of this invention.

DESCRIPTION OF THE PREFERRED EMBODIMENTS Process A polyglycolic acid braid is prepared by conventional methods and wound on creel 11. Braid 10 contained some surface soiling due to prior processing and had a grayish color. Braid 10 is then passed through the solvent-surfactant cleaning bath 12 contained in tank 13 by Godets 14 and 15, being taken up by winder 16. Tank 13 is equipped with appropriate ultrasonic transducers which are connected to ultrasonic generator 13a to ultrasonic agitation of bath fluid 12. Clean braid 17 emerges from bath 12. Winder 16 containing clean braid 17 is then dried in oven 18 to remove bath liquid remaining on the braid.

Bath 12 is continuously recirculated by pump 19 through filter 20 which removes suspended matter in bath 12. Bath overflow 21 is sent to batch still 22 where it is distilled to produce an overhead vapor stream 23 of substantially pure solvent and a bottoms stream 24 consisting of the soil removed from the braid surface as well as some of the surfactant from bath 12. Vapor stream 23 is passed through condenser 25. Condensate 26 is collected in storage tank 27. Make-up surfactant 28, preferably already solubilized in a small amount of solvent, is then fed to tank 27 in an appropriate amount where it is intimately mixed with condensate 26 to form stream 29 which is recycled by pump 30 to bath 12.

In another embodiment of the inventive process, the process is as heretofore described except that cleaned braid 17 emerges from bath 12 and passes into a second tank which contains a surfactant free solvent of the types described hereinbelow which solvent is preferably the same solvent and is used in bath 12. The purpose of this second bath is to rinse away residual surfactant picked up by braid 17 in bath 12. Ordinarily, one rinse bath will sufilce although more than one may be used particularly if the surfactant concentration of bath 12 is high. After braid 17 leaves the rinse baths it is dried in oven 18 to remove solvent.

It is preferable that the amount of surfactant or solvent on the finished suture braid be sufliciently low so as to be non-toxic and non-inflammatory toward tissues.

Bath solvents Among the illustrative organic solvents which can be employed in the process of this invention are:

(1) the aromatics such as benzene, toluene, and xylene (2) cyclic aliphatics such as cyclopentane, cyclohexane, cycloheptane, and cyclooctane (3) aliphatics such as hexane, heptane and octane (4) chlorinated aliphatics such as methylene chloride, chloroform, carbon tetrachloride, 1,1-dichloroethane, 1,1, l-trichloroethane, 1,1,2-trichloroethane, 1,2-dichloroethylene, 1,1,2 trichloroethylene, and trichlorotrifluoroethane (5) ketonic solvents such as acetone, methylisobutylketone, and cyclohexanone (6) kerosene (7) terpentine; and

(8) Stoddard solvent Other solvents having a high afiinity for grease and oil are, of course, also operable in the process of this invention. Xylene is a preferred solvent.

Water although not having an aflinity for grease and oil by itself, is very suitable when mixed with a surfactant. Due to the low cost and high availability of water, it also represents a preferred solvent.

Bath surfactants Surfactants of the anionic, nonionic, and cationic variety are suitable for use in the process of this invention. Due to the difficulty of totally removing surfactant from the cleaned filament, it is essential that the surfactant selected be non-toxic and non-inflammatory towards living tissue and in general be biologically innocuous.

Illustrative surfactants are the nonionic Spans (Atlas Industries) such as sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan tristearate, sorbitan monooleate, sorbitan trioleate; the nonionic Tweens (Atlas Industries) such as polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monopalmitate, polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan tristearate, polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan triolate, said polyoxyethylene compounds containing from 4 to 20 moles of ethylene oxide; anionic surfactants such as lauryl sulfate (Du Pont); and cationic surfactants such as stearamide propyldimethyl-B-hydroxyethyl ammonium nitrate (American Cyanamid).

The selection of the appropriate surfactant will in turn depend upon which solvent has been selected. Since it is essential to obtain solubility of the surfactant in the solvent, a surfactant which is hydrophilic is preferred when the solvent is water while one which is lipophilic is preferred when the solvent is of an organic origin. A particularly useful method of matching surfactant and solvent is through the use of the HLB (hydrophile-lipophile balance) System developed by Atlas Industries. This system assigns a surfactant a numerical place on a scale running from 0 to 20. This number is called the HLB value. The lower the HLB value, the more hydrophlic (water-loving) is the material. Those in the HLB range of 10-11 are intermediates. In general, materials of low HLB value tend to be Oil-soluble, and those of high HLB tend to be water-soluble. The procedure for procuring the HLB value for a particular surfactant is well-known and does not bear repeating herein.

-If water is the solvent of choice, surfactants having a HLB value in excess of ten, and preferably in excess of 14, are suitable since sufiicient solubility of the surfactant 1s achieved to give the desired efficacy. In the case of water, a preferred surfactant is polyoxyethylene sorbitan monooleate containing 20 moles of ethylene oxide. This surfactant has an HLB value of 15 and is sold commercially as Tweenby Atlas Industries. This surfactant is preferred not only because it is readily soluble in water but also because it is known to be physiologically innocuous and has already been approved by the Federal Food and Drug Administration for internal consumption in such items as food and candy. It has also been approved for use in intravenous and intramuscular pharmaceutical preparation such as those of tetracycline and chlortetracycline. This surfactant is listed under the name Polysorbate 80 in the Merck Index, 7th ed. (1960) at pg. 833 and in the US. Pharmacopoeia XV at pg. 566, said publications incorporated herein by reference.

If an organic solvent is to be used, surfactants having an HLB value less than ten, and preferably less than 5 are preferred. Preferred surfactants in this case are sorbitan monostearate (HLB value of 4.7) and sorbitan monooleate (HLB value of 4.3), said surfactants sold commercially as Span-60 and Span-80, respectively, by Atlas Industries. These surfactants are preferred not only for their high solubility in organic solvents but because they also are known to be biologically innocuous having properties similar to Tween-80.

The amount of surfactant may vary from about 1% to about 10% based on the total weight of the cleaning bath. An amount of 1% is required to obtain a suitable rate of cleaning. Amounts in excess of 10% do not appreciably increase the rate of cleaning and have the disadvantage of king it more 'ditficult to thoroughly re- W move the surfactant from the filament.

H As thesurfactant concentration is increased from 1% to the rate of cleaning is improved; however, the removal'of'the surfactant becomes a greater problem; Therefore, it is desirable to use as small an amount of surfactant as is compatible with effective cleaning. A preferred amount is about 1 to 2%.

1 Ultrasonic agitation generally somewhat" above a level that can be heard.

Since sound is a compressional wave, the action of this high frequency energy in a liquid may be considered as the rapid generation and violet collapse of minute bubbles. .Countless small but intense impacts erode surface soil from the immersed polyglycolic acid filament. This action is called cavitation. 'It wears away surface soil.

I? In a typical ultrasonic cleaning operation, a generating unit provides electrical energy at a desired frequency. This energy is fed to one or more transducers wherein the electrical energy is converted into mechanical energy -(vibrations) which are then transmitted into the solution which is ordinarily contained in a tank. A generator will typically produce frequencies ranging from .10 to 120 kilocycles Bath conditions 'Bath temperatures can vary from C. to 100 C. Temperature appears to have no significant effect on the cleaning procedure. In a preferred embodiment, the bath with 10, 25, 40, 90, and 120 kilocycle generators repre- The power level at which the electrical energy of constant frequency is sent to the transducer will vary depending upon the number of transducer elements required for effective transmission of mechanical energy into the solution. This, of course, depends on the quantity of solution to be ultrasonically agitated. As a rule, as solvent volume increases, the number of transducers required also increases warranting a corresponding increase in power input. For example, a large solvent tank, i.e. 1 6" x 16" x 16" may require from 18 to 24 transducers for effective cleaning with a power output of about 1000 watts being required. On the other hand, a smaller tank, i.e. 8 x 10" x 10" may only require 6 to 12 transducers for effective cleaning with a power output of only 500 watts being required.

The power output of a generator is readily adjusted by installing a rheostat in the generator input line. For most operations power outputs of -1000 watts are sufficient. However for very large volumes of solvent larger power inputs may be required.

The simplest ultrasonic cleaning system consists of an ultrasonic generator and a transducerized tank. In this case, transducer elements are mounted externally to the bottom or sides of the tank leaving the inside surfaces of the cleaning chamber smooth. Alternatively, irnmersible type transducers may be mounted directly in the solution in the tank. These transducers may be in the form of hermetically sealed stainless steel cases which contain the active elements mounted to one inner side. lm'mersible transducers are preferred in larger systems.

is initially at room temperature (20-25 C.) until ultrasonic vibration of the bath is initiated whereupon the temperature can gradually rise to as high as 70 C., and typically to 40-60 C.

Bath temperatures in excess of C. must be avoided since higher temperatures, particularly when the solvent is water, can seriously degrade the polyglycolic acid causing appreciable losses in the package and in-vivo tensile strength of the resulting suture.

The residence time of the filament in the bath must be at least 10 seconds for suitable cleaning. The filament can be left in the bath for as long as desired. However,

I in the casewhere water is the solvent, short residence EXAMPLE 1 A length of braided size 3-0 polyglycolic acid suture was prepared in a conventional manner. The suture was artificially surface soiled to produce a uniformly gray color with occasional darker highlights; the usual color of clean braid is an unblemished pearl or light cream.

The soiled suture length was then drawn through xylene which contained 1% sorbitan monooleate (Span-80, Atlas Industries) dissolved therein. The xylene/ Span-80 solution was contained in a 4" x 18" x 5" (about 2 gallons) tank and was ultrasonically agitated using (1) a Branson ultrasonic generator, model 520, 40 kilocycles, having an input of 440 watts at volts, 60 cycle, single phase, and an output of 700 watts on peak pulses and 350 watts average and (2) a Branson Sonogen-Z cleaning tank, Model AT-848S, 316L stainless steel (16 gauge) containing 8 transducer elements. The residence time of the. suture in the bath was about 10 seconds. The original temperature of the bath was about 23 C.; however, the ultrasonic vibration within the bath raised its temperature to about 60 C. during treatment.

The cleaned suture was then dried in a forced draft oven for 2 hours at 40 C. The color of the suture was unblemished pearl. A comparison of the cleaned and uncleaned braid revealed a striking difference in the color of the two braids thereby showing the efficacy of the cleaning procedure. The cleaned braid was implanted in rabbits using known test procedures. No discernible differences in either in-vivo strength or effect upon living tissue were observed as compared to ordinary braid which did not require cleaning thereby indicating that the cleaning process of this invention produces no adverse effect upon the properties of the suture.

EXAMPLES 2 TO 17 Following substantially the same procedure as in Example l the effect of a variety of process variables upon braid cleaning was investigated. Results are shown below in Table I.

TABLE I Bath conditions Braid residence Temp. time Suture Adequately Ex. No. Solvent Surfactant Percent 0.) (seconds) size Color in Color out cleaned 2 100 20 do Sorbitan trioleate 2 55 10 Carbon tetrachloride Sorbitan monooleate 1 120 7. Chloroform do 1 120 8. Terpentine Sorbitan monostearat 1 10 9. 1,1,1-trichloroetl1an Sorbitan monooleate 1 40 0 10 1,1,2-trichloroethylen Sorbitan monopalmitate 3 100 Sorbitan monooleate 1 30 25 Polyoxyethylene sorbitan 1 40 10 monooleate 13 do "do 5 25 120 "do 10 35 25 Polyoxyethylene sorbitan 1 50 0 monostearate 1G do Lauryl sulfate 5 1Q 17 d0 Stearamide propyldunethyl- 5 0 B-hydroxyethyl.

1 With occasional darker highlights. 2 20 moles of ethylene oxide.

We claim:

1. A process for removing surface soil from a filament of polyglycolic acid destined for use as an absorbable surgical suture which comprises contacting said soiled filament at least once with an ultrasonically agitated solution comprising:

(a) a solvent selected from the group consisting of: water and an organic solvent having an afiinity to dissolve, emulsify or entrain oily, greasy substances; and

(b) a surfactant which is biologically innocuous towards living tissue, the amount of said surfactant in the solution ranging from about 1% to about 10% by weight of the total solution at temperatures ranging from about 20 C. to 100 C. for at least about 10 seconds.

2. The process of claim 1 wherein the solvent is selected from the group consisting of water, aromatics, cyclic aliphatics, aliphatics, chlorinated aliphatics, ketones, terpentine, kerosene, and Stoddard solvent.

3. The process of claim 1 wherein the solvent is water.

4. The process of claim 3 wherein the surfactant is polyoxyethylene sorbitan monooleate containing about 20 moles of ethylene oxide and is present in the amount of about 1%.

5. The process of claim 4 further including the step References Cited UNITED STATES PATENTS 2,484,014 10/1949 Peterson et a1. 134-1X 3,007,478 11/1961 Leonhardt et al. 1341X 3,034,520 5/1962 Jewell 1341X 3,050,422 8/1962 Zak 134-1 MORRIS O. WOLK, Primary Examiner J. T. ZATARGA, Assistant Examiner US. Cl. X.R. 13415, 17

UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Patent No. 3 600 2Z5 Dated August 17 1971 Inventor(s) Arthur G1 iCk et a1 It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:

Column 5, line 22, "violet" should read violent Table I, Ex. No. 3, "Gray" should read Gray Table I, Ex. N0. 4, ".0" should read 3-0 Signed and sealed this 11th day of April 1972.

(SEAL) Attest:

EDWARD M.FLETCHER,JR. ROBERT GOTTSCHALK Attesting Officer Commissioner of Patents FORM PO-1 6 7 USCOMM-DC B0376-PG9 i ,5. GOVERNMENT PRINTING OFFCE IBIS 0-36G-334

Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3954635 *Dec 23, 1974May 4, 1976American Cyanamid CompanyPolyglycolic acid fiber finish and method
US4244078 *Apr 26, 1979Jan 13, 1981Research Technology, Inc.Method and apparatus for cleaning film
US4337096 *Nov 10, 1980Jun 29, 1982Paul L. PrattMethod and implement for cleaning drains
US4788992 *Apr 28, 1987Dec 6, 1988Lewis CorporationUltrasonic strip cleaning apparatus
US5466406 *Jun 7, 1994Nov 14, 1995United States Surgical CorporationProcess of treating filaments
US7791802Jun 23, 2008Sep 7, 2010Illumina, Inc.Optical identification element having a non-waveguide substrate
US7796333Sep 23, 2008Sep 14, 2010Illumina, Inc.Encoded microparticles and a method for fabricating
US7830575Apr 10, 2007Nov 9, 2010Illumina, Inc.Optical scanner with improved scan time
US7843567Dec 22, 2009Nov 30, 2010Illumina, Inc.Methods of identifying an analyte and nucleic acid analysis
US7872804Oct 10, 2006Jan 18, 2011Illumina, Inc.Encoded particle having a grating with variations in the refractive index
US7898735Mar 21, 2008Mar 1, 2011Illumina, Inc.Methods and systems for writing an optical code within or on a fiber substrate
US7900836Jul 16, 2008Mar 8, 2011Illumina, Inc.Optical reader system for substrates having an optically readable code
US7901630Sep 13, 2005Mar 8, 2011Illumina, Inc.Diffraction grating-based encoded microparticle assay stick
US7923260Oct 6, 2006Apr 12, 2011Illumina, Inc.Method of reading encoded particles
US8049893Nov 8, 2010Nov 1, 2011Illumina, Inc.Methods of identifying analytes and using encoded particles
US8081792Nov 16, 2005Dec 20, 2011Illumina, Inc.Fourier scattering methods for encoding microbeads and methods and apparatus for reading the same
US8333325Jan 26, 2011Dec 18, 2012Illumina, Inc.Optical reader system for substrates having an optically readable code
US8470605Mar 20, 2009Jun 25, 2013Illumina, Inc.Optical reader for reading encoded microparticles
US8498052Sep 14, 2009Jul 30, 2013Illumina, Inc.Composition including an item and an encoded optical substrate and a method for identifying an item
US8565475Sep 23, 2011Oct 22, 2013Illumina, Inc.Optical system and method for reading encoded microbeads
US8614852Sep 7, 2010Dec 24, 2013Illumina, Inc.Elongated microparticles having an optically detectable code configured to at least one of reflect or filter light
Classifications
U.S. Classification134/1, 134/15, 134/17
International ClassificationA61L17/00, A61L17/12
Cooperative ClassificationA61L17/12
European ClassificationA61L17/12